Zepp Health (NYSE:ZEPP) Trading Down 1% – Here’s What Happened
by Amy Steele · The Cerbat GemZepp Health Corporation Sponsored ADR (NYSE:ZEPP – Get Free Report)’s share price fell 1% on Wednesday . The company traded as low as $27.70 and last traded at $28.26. 56,133 shares traded hands during trading, a decline of 68% from the average session volume of 173,877 shares. The stock had previously closed at $28.54.
Analyst Ratings Changes
ZEPP has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Zepp Health in a research report on Wednesday, October 8th. Fundamental Research set a $64.37 price objective on Zepp Health and gave the stock a “buy” rating in a research report on Tuesday, November 11th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $64.37.
View Our Latest Analysis on ZEPP
Zepp Health Price Performance
The stock has a market cap of $409.77 million, a P/E ratio of -6.88 and a beta of 1.41. The business’s 50 day moving average price is $32.29 and its two-hundred day moving average price is $29.48. The company has a current ratio of 1.09, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31.
Zepp Health (NYSE:ZEPP – Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported ($0.04) EPS for the quarter. The company had revenue of $75.79 million during the quarter. Zepp Health had a negative return on equity of 21.45% and a negative net margin of 28.28%.
Institutional Investors Weigh In On Zepp Health
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Trivest Advisors Ltd purchased a new position in Zepp Health during the third quarter valued at $13,503,000. Millennium Management LLC bought a new position in shares of Zepp Health in the 3rd quarter worth about $11,265,000. UBS Group AG lifted its position in Zepp Health by 16,412.0% during the 3rd quarter. UBS Group AG now owns 181,302 shares of the company’s stock valued at $8,300,000 after acquiring an additional 180,204 shares during the period. Keystone Investors PTE Ltd. bought a new stake in Zepp Health during the third quarter worth about $4,811,000. Finally, Lighthouse Investment Partners LLC purchased a new stake in Zepp Health in the third quarter worth about $2,070,000. 52.61% of the stock is owned by hedge funds and other institutional investors.
Zepp Health Company Profile
Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.
At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.